Company intelligence / Profile preview

Ceban Ziekenhuisfarmacie

Oostrum, Limburg or North Brabant*, Netherlandsnl.linkedin.com ↗

Ownership: Private
Employees: ~600
Development stage: Commercial

Overview

Ceban Ziekenhuisfarmacie specializes in the manufacture and compounding of pharmaceutical products for hospitals and pharmacies. It produces approximately 15,000 personalized medication preparations per year and supplies over 500 specialty pharmaceutical raw materials. The company was acquired by Medios in June 2024[2][4].

Therapeutic areas: Other
Modalities: Small moleculeBiologicPersonalized medication preparations (compounded drugs)
Industry: Contract Manufacturing Organization

Partnerships

Hospitals across the Netherlands and Europe[1][3]

Beyond the preview

Go deeper on Ceban Ziekenhuisfarmacie.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceban Ziekenhuisfarmacie.

Explore the full profile